- Nov 24/22
New CRISPR gene-editing system can “drag-and-drop” DNA in bulk - Nov 24/22
CAR T Cell Therapy reaches beyond cancer - Nov 23/22
Gene therapy at $3.5m a dose approved for US adults with hemophilia B - Nov 23/22
Sanford Stem Cell Institute launches stem cells into space - Nov 22/22
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B - Nov 22/22
FDA extends deadline to decide on Gamida Cell’s stem cell transplant therapy by three months - Nov 21/22
CAR T-cell therapy in colorectal cancer - Nov 17/22
Real-world evidence study of regenerative medicine and shoulder surgery - Nov 17/22
Gene Therapy for Hemophilia Is on the Brink of FDA Approval - Nov 17/22
Drug discovery and development—in space - Nov 16/22
The expanding patent landscape for RNA-based therapeutics - Nov 16/22
Leprosy: Ancient disease able to regenerate organs - Nov 14/22
Early cell therapy successes start to turn the tide in lupus - Nov 14/22
Scientists look to grow ‘mini livers’ for patients with organ damage - Nov 13/22
“Seminal” study gene edits immune cells to target cancer - Nov 11/22
Building an integrated vector supply to support autologous cell therapy for solid tumours - Nov 10/22
Monoclonal antibodies preserve stem cells in mouse brains, bring promise for future studies - Nov 10/22
Blood Stem Cell Transplant Could Reboot Immune System in Multiple Sclerosis Patients - Nov 10/22
CAR T-cell therapy outcomes similar across different socioeconomic levels among pediatric patients with ALL - Nov 9/22
Silicon nanochip could treat traumatic muscle loss - Nov 8/33
ExCellThera announces 100th patient treated with UM171-expanded cell therapy - Nov 8/22
Gene therapy targeting select brain cells may treat Parkinson’s - Nov 8/22
Stem cells may help replace lost sensory neurons - Nov 7/22
Western University student hosts stem cell drive to ethnically diversify Canada’s blood supply - Nov 7/22
Epilepsy: gene therapy technique targeting overactive brain cells shows promise in treating drug-resistant form of the condition - Nov 7/22
Hearing loss gene therapy treatment given FDA rare pediatric disease designation - Nov 6/22
Lab-grown blood given to people in world-first clinical trial - Nov 3/22
Cost watchdog ICER backs multimillion-dollar price tags for BioMarin, CSL hemophilia gene therapies - Nov 2/22
Scientists discover changes in aging stem cells - Nov 2/22
An NK cell therapy biotech pulls IPO ambitions weeks after second trial clearance - Nov 1/22
Cell and gene therapy: current challenges and the benefits of automation - Nov 1/22
Trial of stem cell-derived therapy for Parkinson’s to open in Sweden - Nov 1/22
Ground-breaking stem cell procedure restores patient’s mobility and joy for life - Oct 31/22
Stem cell protein linked to relapse of pediatric brain tumours - Oct 31/22
Proteins “slide” genetic instructions into cell in new gene therapy approach - Oct 27/22
Stem cell-derived organoids mimic human parathyroid tissue - Oct 27/22
Vancouver is ready to foster the next generation of biotech companies - Oct 27/22
Researchers home in on a new cause of Stargardt disease - Oct 27/22
Gene editing feasibility established for inborn error of immunity - Oct 25/22
Chardan analyst assesses genome editing’s dazzling potential, stubborn challenges - Oct 25/22
Life Science Leader’s annual industry outlook issue: What didn’t make it to print - Oct 24/22
FDA finalizes neurodegenerative disease gene therapy guidance - Oct 24/22
Enhanced genome editing toolkit focuses on delivery and precision - Oct 23/22
New findings shed light on the mystery of how cells handle stress - Oct 21/22
Gene therapy: How can poorer countries access the most expensive drugs in the world? - Oct 20/22
Stem cell study reveals how neurons from PTSD patients react to stress - Oct 19/22
Stem cell-derived therapy eases motor deficits in Parkinson’s model - Oct 18/22
The influenza virus and its influence on blood stem cells and coagulation - Oct 18/22
A sound approach for effective gene therapy delivery to the brain - Oct 18/22
Improved understanding of early spinal cord development paves the way for new treatments - Oct 17/22
Manufacturing remains big challenge for cell and gene therapy industry - Oct 13/22
Changes in the skin microbiome may contribute to development of GVHD after stem cell transplant - Oct 13/22
Mathematical model could bring us closer to effective stem cell therapies - Oct 12/22
Approval, commercialization highlighted at cell & gene Meeting on the Mesa - Oct 11/22
Second patient receives landmark fetal surgery and stem cell procedure - Oct 11/22
Improved AAV could cross blood-brain barrier and deliver gene therapies to CNS - Oct 10/22
Gene therapy rapidly improves night vision in adults with congenital blindness, Penn study finds - Oct 7/22
Researchers take new approach to studying the development of the human brain - Oct 6/22
Stem cell patch surgery to mend spina bifida in the womb - Oct 6/22
Stem cell-based genomic study yields insights on viral infection susceptibility - Oct 6/22
Second type of stem cell discovered in the mouse brain - Oct 6/22
Accelerating gene therapy manufacturing with integrated solutions - Oct 4/22
Production of telomerase RNA by dual-function mRNA could inform future antiaging strategies - Oct 4/22
Rare autoimmune mechanism revealed using gene editing in mouse models - Oct 3/22
Study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention - Sept 29/22
Mass producing biodegradable stem cell therapy microrobots - Sept 29/22
Pluripotent bat stem cells as a model to study novel viruses - Sept 28/22
Live imaging and cellular barcoding reveal how new stem cells are vetted for quality - Sept 27/22
Effective medical communications during CGT clinical trials - Sept 27/22
Cutting-edge blood cancer treatment with shorter wait times on the horizon for Canadians - Sept 26/22
Split prime editing systems broaden research and therapeutic uses - Sept 26/22
Cloned minipigs support fourth gene mutation as causal for Alzheimer’s disease - Sept 26/22
Rational treatment strategies for SARS-CoV-2 derived from human pluripotent stem cells models - Sept 26/22
Prime Medicines files for IPO, revealing 18-program pipeline and first patent
